Altimmune Newsroom

B.Riley Financial Maintains Altimmune(ALT.US) With Buy Rating, Maintains Target Price $20

Moomoo NewsDec 20 14:31 ET

B.Riley Financial Keeps Their Buy Rating on Altimmune (ALT)

TipRanksDec 20 13:42 ET

H.C. Wainwright Maintains Altimmune(ALT.US) With Buy Rating, Maintains Target Price $12

Moomoo NewsNov 13 11:31 ET

Altimmune's Pemvidutide Progress and Expansion: A Buy Recommendation by Patrick Trucchio

TipRanksNov 13 11:08 ET

Evercore Maintains Altimmune(ALT.US) With Buy Rating, Maintains Target Price $25

Moomoo NewsNov 13 09:33 ET

Altimmune (ALT) Receives a Buy From Evercore ISI

TipRanksNov 13 08:40 ET

B.Riley Financial Maintains Altimmune(ALT.US) With Buy Rating, Maintains Target Price $20

Moomoo NewsNov 13 08:31 ET

Altimmune Analyst Ratings

BenzingaNov 12 08:48 ET

UBS Initiates Altimmune(ALT.US) With Buy Rating, Announces Target Price $26

Moomoo NewsNov 12 05:37 ET

Altimmune's Pemvidutide: A Promising Buy Rating for Metabolic Health Breakthroughs

TipRanksNov 12 05:14 ET

Altimmune Initiated With a Buy at UBS

TipRanksNov 12 04:59 ET

Evercore Maintains Altimmune(ALT.US) With Buy Rating, Maintains Target Price $25

Moomoo NewsNov 8 09:31 ET

Analysts Are Bullish on Top Healthcare Stocks: Altimmune (ALT), Hansa Biopharma AB (SE:HNSA)

TipRanksOct 9 05:02 ET

Piper Sandler Maintains Altimmune(ALT.US) With Buy Rating, Maintains Target Price $25

Moomoo NewsOct 4 08:31 ET

Analysts Offer Insights on Healthcare Companies: Abbott Laboratories (ABT), Altimmune (ALT) and Steris (STE)

TipRanksOct 4 08:15 ET

JMP Securities Maintains Altimmune(ALT.US) With Buy Rating, Maintains Target Price $24

Moomoo NewsSep 30 10:31 ET

JMP Securities Maintains Altimmune(ALT.US) With Buy Rating, Maintains Target Price $24

Moomoo NewsSep 11 01:32 ET

JMP Securities Maintains Altimmune(ALT.US) With Buy Rating, Maintains Target Price $24

Moomoo NewsSep 10 17:32 ET

Buy Rating Affirmed for Altimmune on Pemvidutide's Positive Trial Data and Strategic Advancements

TipRanksSep 10 16:37 ET

Altimmune Analyst Ratings

BenzingaAug 22 13:40 ET